Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study).

Thomas WolffHolger SchulzChristoph LosemDietmar ReichertHans-Jürgen HurtzReiner SandnerJohanna HardeSina GrebhardtKarin PotthoffUdo MuellerThomas Fietz

Published in: European journal of haematology (2018)

Prophylaxis or therapeutic intention with lipegfilgrastim in NHL patients in routine clinical practice showed similar effectiveness and safety as demonstrated in the pivotal trials.

Keyphrases

chemotherapy induced
clinical practice
end stage renal disease
chronic kidney disease
newly diagnosed
prognostic factors